Who owns Swirsky Douglas J?

No ownership or control links for Swirsky Douglas J are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

What is Swirsky Douglas J's risk level?

WhiteIntel flags Swirsky Douglas J as medium risk. Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.

Where does Swirsky Douglas J appear across sources?

Swirsky Douglas J is indexed in the WhiteIntel corporate-ownership graph (US), with a source on every claim.

LIVE · CORPUS

Dossier

●

Swirsky Douglas J

Name: Swirsky Douglas J — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, Swirsky Douglas J, Person, US

Medium

PersonUS

View network JSON / MCPsample

Fig. 01 — Cross-source signature

/01

Key facts

Risk signal

Controls: 14 companies
Risk: Medium
Jurisdiction: US

Medium

Risk

Swirsky Douglas J controls or directs 14 companies (US).

/02

Control & directorships

Controlled by

None in current sources.

Directorships & controlled companies

Swirsky Douglas J
- MAXCYTE, INC.· officer· via sec_form345
- MAXCYTE, INC.· officer· via sec_form345
- Cellectar Biosciences, Inc.· director· via sec_form345
- Barinthus Biotherapeutics plc.· officer· via SEC EDGAR
- MAXCYTE, INC.· officer· via SEC EDGAR
- Cellectar Biosciences, Inc.· director· via SEC EDGAR
- MetaVia Inc.· director· via SEC EDGAR
- AMERICAN FINANCIAL HOLDING INC /DE· director· via SEC EDGAR
- Opus Genetics, Inc.· director· via SEC EDGAR
- Opus Genetics, Inc.· officer· via SEC EDGAR
- GOLF TRUST OF AMERICA INC· director· via SEC EDGAR
- GENVEC INC· director· via SEC EDGAR
- GENVEC INC· officer· via SEC EDGAR
- BTHC II ACQUISITION CORP· director· via SEC EDGAR

/ Community notesFREE

Analyst context the registries don’t carry — corrections, links, open questions on Swirsky Douglas J. Notes are community-contributed leads, not verified facts.

Loading notes…